Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/21338186

Download in:

View as

General Info

PMID
21338186